The Role of Clinical Trials in Veterinary Oncology

被引:10
作者
Burton, Jenna [1 ]
Khanna, Chand [2 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA
[2] NCI, Ctr Canc Res, Pediat Oncol Branch, Tumor & Metastasis Biol Sect,Comparat Oncol Progr, Bethesda, MD 20892 USA
关键词
Clinical trials; Veterinary; Comparative oncology; Pathobiology; SOCIETY; DESIGNS; DOGS;
D O I
10.1016/j.cvsm.2014.05.006
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Clinical trials for companion animals are becoming more common and more accessible to pet owners as veterinary oncologists seek to expand their knowledge of tumor biology in companion animal species and improve the way they diagnose and treat cancer for these animals. Many owners enroll their pets because they wish to participate in clinical cancer research that may ultimately benefit pets and people. Understanding the goals, benefits, and risks of clinical trials participation provides the knowledge needed by primary care veterinarians to counsel their clients as to whether clinical trial participation is a good choice for them and their pets.
引用
收藏
页码:977 / +
页数:13
相关论文
共 17 条
[1]  
[Anonymous], 2019, ONCOL
[2]   Phase I clinical trial design in cancer drug development [J].
Eisenhauer, EA ;
O'Dwyer, PJ ;
Christian, M ;
Humphrey, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :684-692
[3]   The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway [J].
Gordon, Ira ;
Paoloni, Melissa ;
Mazcko, Christina ;
Khanna, Chand .
PLOS MEDICINE, 2009, 6 (10)
[4]   Methods for Adjusting for Bias Due to Crossover in Oncology Trials [J].
Ishak, K. Jack ;
Proskorovsky, Irina ;
Korytowsky, Beata ;
Sandin, Rickard ;
Faivre, Sandrine ;
Valle, Juan .
PHARMACOECONOMICS, 2014, 32 (06) :533-546
[5]   Improvement of informed consent and the quality of consent documents [J].
Jefford, Michael ;
Moore, Rosemary .
LANCET ONCOLOGY, 2008, 9 (05) :485-493
[6]   Drug development in oncology: classical cytotoxics and molecularly targeted agents [J].
Kummar, Shivaani ;
Gutierrez, Martin ;
Doroshow, James H. ;
Murgo, Anthony J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) :15-26
[7]   Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies [J].
Kummar, Shivaani ;
Doroshow, James H. ;
Tomaszewski, Joseph E. ;
Calvert, A. Hilary ;
Lobbezoo, Marinus ;
Giaccone, Giuseppe .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (05) :741-746
[8]   Randomized phase II designs in cancer clinical trials: Current status and future directions [J].
Lee, JJ ;
Feng, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4450-4457
[9]  
McLemore Monica R, 2006, Clin J Oncol Nurs, V10, P153, DOI 10.1188/06.CJON.153-154
[10]  
Nguyen SM, 2013, VET COMP ONCOL